Live Breaking News & Updates on Ydus Life Drug Launch

Stay updated with breaking news from Ydus life drug launch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zydus Life gains over 3% on launch of bladder control drug

Incred Equities estimates Mirabegron to be a $75-80 million opportunity for Zydus Lifesciences, as the company also enjoys a 180-day exclusivity period ....

Zydus Lifesciences , Aurobindo Pharma , Zydus Lifescience , National Stock Exchange , Drug Administration , Zydus Life , National Stock , Incred Equities , Alkem Labs , Emerging Markets , Uzzing Stocks , Ydus Life Drug Launch , Ydus Life Bladder Drug , Drug Launch , Ydus Life Stock Reaction , Zydus Life Share Price ,